In vivo anti-angiogenic effects further support the promise of the antineoplasic activity of methyl jasmonate.
Pereira Lopes, J E F
In vivo anti-angiogenic effects further support the promise of the antineoplasic activity of methyl jasmonate. [electronic resource] - Brazilian journal of biology = Revista brasleira de biologia May 2010 - 443-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1678-4375
10.1590/s1519-69842010000200029 doi
Acetates--pharmacology
Angiogenesis Inhibitors--pharmacology
Animals
Antineoplastic Agents--pharmacology
Cell Line, Tumor
Chick Embryo
Chorioallantoic Membrane--blood supply
Cyclopentanes--pharmacology
Endothelial Cells--cytology
Humans
Oxylipins--pharmacology
Umbilical Veins--cytology
In vivo anti-angiogenic effects further support the promise of the antineoplasic activity of methyl jasmonate. [electronic resource] - Brazilian journal of biology = Revista brasleira de biologia May 2010 - 443-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1678-4375
10.1590/s1519-69842010000200029 doi
Acetates--pharmacology
Angiogenesis Inhibitors--pharmacology
Animals
Antineoplastic Agents--pharmacology
Cell Line, Tumor
Chick Embryo
Chorioallantoic Membrane--blood supply
Cyclopentanes--pharmacology
Endothelial Cells--cytology
Humans
Oxylipins--pharmacology
Umbilical Veins--cytology